Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2011 Nov;30(11):962-6.
doi: 10.1097/INF.0b013e318232ede9.

Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study

Susan E Coffin  1 , Kateri Leckerman, Ron Keren, Matthew Hall, Russell Localio, Theoklis E Zaoutis
Affiliations
Multicenter Study

Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study

Susan E Coffin et al. Pediatr Infect Dis J. 2011 Nov.

Abstract

Background: Antiviral therapy reduces symptom duration and hospitalization risk among previously healthy and chronically ill children infected with seasonal influenza. The effect of oseltamivir on outcomes of hospitalized children is unknown. The primary objective of this study was to determine whether oseltamivir improves outcomes of critically ill children hospitalized with influenza.

Methods: We performed a retrospective cohort study of children with influenza infection admitted to a pediatric intensive care unit during 6 consecutive winter seasons (2001-2007). We used the Pediatric Health Information System database, which contains resource utilization data from 41 children's hospitals. We matched oseltamivir-treated patients with oseltamivir-nontreated patients by the probability of oseltamivir exposure using a propensity score we derived from patient and hospital characteristics. We subsequently compared the outcomes of critically ill children treated with oseltamivir within 24 hours of admission with propensity score matched children who were not treated with oseltamivir.

Results: We identified 1257 children with influenza infection, 264 of whom were treated with oseltamivir within 24 hours of hospital admission. Multivariable analysis of 252 oseltamivir-treated patients and 252 propensity score-matched untreated patients demonstrated that patients treated with oseltamivir experienced an 18% reduction in total hospital days (time ratio: 0.82, P = 0.02), whereas intensive care unit stay, in-hospital mortality, and readmission rates did not differ.

Conclusion: For critically ill children infected with seasonal influenza, treatment with oseltamivir within 24 hours of hospitalization was associated with a shorter duration of hospital stay. Additional study is needed to determine the effect of delayed initiation of oseltamivir on clinical outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Assembly of the study cohort.
See this image and copyright information in PMC

Comment in

References

    1. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. New England Journal of Medicine. 2006 Jul 6;355(1):31–40. see comment. - PubMed
    1. CDC. Influenza Activity --- United States and Worldwide, May 18--September 19, 2008. MMWR - Morbidity & Mortality Weekly Report. 2008;57(38):1046–1049. - PubMed
    1. Centers for Disease Control and P. Notifiable Diseases/Deaths in Selected Cities Weekly Information. MMWR - Morbidity & Mortality Weekly Report. 2009 May 8;58(17):474–485.
    1. Keren R, Zaoutis T, Bridges C, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. Journal of the American Medical Association. 2005;294:2188–2194. - PubMed
    1. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. New England Journal of Medicine. 2005 Dec 15;353(24):2559–2567. - PubMed

Publication types

MeSH terms